(-0.21%) 5 202.00 points
(-0.21%) 39 112 points
(-0.28%) 18 135 points
(1.00%) $79.78
(-1.23%) $2.16
(-0.12%) $2 319.50
(1.14%) $27.92
(0.57%) $990.20
(0.18%) $0.932
(0.31%) $10.92
(0.32%) $0.803
(0.99%) $92.65
Quarter results today
(bmo 2024-05-09)
Expected move: +/- 0.00%
0.98% $ 2.07
Live Chart Being Loaded With Signals
Indaptus Therapeutics, Inc., a pre-clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical oncology candidate is Decoy20 to single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as hepatitis B virus and human immunodeficiency virus infection, which is in Phase I clinical trial...
Stats | |
---|---|
Volumen de hoy | 5 706.00 |
Volumen promedio | 90 096.00 |
Capitalización de mercado | 17.68M |
EPS | $0 ( 2024-05-03 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -1.130 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-22 | Linscott Walt Addison | Buy | 75 000 | Stock Option (Right to Buy) |
2024-01-22 | Waltzman Roger J. | Buy | 75 000 | Stock Option (Right to Buy) |
2024-01-22 | Sassi Nir | Buy | 40 000 | Stock Option (Right to Buy) |
2024-01-22 | Meckler Jeffrey A | Buy | 100 000 | Stock Option (Right to Buy) |
2024-01-22 | Newman Michael James | Buy | 43 250 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
100.00 |
Last 90 transactions |
Buy: 2 551 706 | Sell: 72 874 |
Indaptus Therapeutics, Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Indaptus Therapeutics, Finanzas
Annual | 2023 |
Ingresos: | $0 |
Beneficio Bruto: | $-1 284.00 (0.00 %) |
EPS: | $-1.840 |
FY | 2023 |
Ingresos: | $0 |
Beneficio Bruto: | $-1 284.00 (0.00 %) |
EPS: | $-1.840 |
FY | 2022 |
Ingresos: | $0 |
Beneficio Bruto: | $-1 781.00 (0.00 %) |
EPS: | $-1.660 |
FY | 2021 |
Ingresos: | $0.00 |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-1.890 |
Financial Reports:
No articles found.
Indaptus Therapeutics,
Indaptus Therapeutics, Inc., a pre-clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical oncology candidate is Decoy20 to single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as hepatitis B virus and human immunodeficiency virus infection, which is in Phase I clinical trial. The company was formerly known as Intec Parent, Inc. and changed its name to Indaptus Therapeutics, Inc. in August 2021. Indaptus Therapeutics, Inc. was incorporated in 2021 and is headquartered in New York, New York.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico